Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

5.21
+0.44009.22%
Post-market: 5.290.0781+1.50%19:59 EDT
Volume:18.07M
Turnover:94.18M
Market Cap:1.03B
PE:6.60
High:5.45
Open:5.20
Low:5.09
Close:4.77
52wk High:5.45
52wk Low:3.49
Shares:196.94M
Float Shares:123.00M
Volume Ratio:10.07
T/O Rate:14.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7896
EPS(LYR):-0.1748
ROE:89.58%
ROA:48.84%
PB:3.97
PE(LYR):-29.80

Loading ...

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16

Arbutus Files Patent Infringement Suits Against Pfizer, Biontech over LNP Technology

Reuters
·
Jul 16

Arbutus Biopharma Corp - Anticipates Receipt of Dividend from Genevant in Q3 2026

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Co and Genevant File Lawsuit in Canada Seeking Injunction and Damages Against Pfizer/biontech

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Expects to Return up to $230 Mln in Capital to Shareholders

THOMSON REUTERS
·
Jul 16

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and Biontech, Receives First Payment from Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Receives About $178 Mln from Moderna Under March 2026 Settlement Agreement

THOMSON REUTERS
·
Jul 16

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

GlobeNewswire
·
Jul 16

Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan

TIPRANKS
·
May 28

Arbutus Biopharma shareholders approve 2026 omnibus share, incentive plan at annual meeting

Reuters
·
May 28

Arbutus Biopharma Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Arbutus Biopharma Swings to Profit in Q1, Revenue Rises; Shares Up Pre-Bell

MT Newswires Live
·
May 13

Arbutus Biopharma Q1 EPS $0.87 Beats $(0.04) Estimate, Sales $179.126M Beat $750.000K Estimate

Benzinga Earnings
·
May 13

Arbutus Biopharma Q1 revenue surges on Moderna settlement

Reuters
·
May 13

Arbutus Biopharma Q1 Revenue USD 179.1 Million

THOMSON REUTERS
·
May 13

Arbutus Biopharma Q1 EPS USD 0.87

THOMSON REUTERS
·
May 13

Earnings Flash (ABUS) Arbutus Biopharma Posts Q1 EPS $0.87, vs. FactSet Est of $0.03 Loss

MT Newswires Live
·
May 13

Arbutus Q1 FY26 net income turns to USD 169.7 million; revenue rises to USD 179.1 million

Reuters
·
May 13

Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Top News Today: Stocks Mixed, Oil Rises After Hot Inflation Data

Dow Jones
·
May 13